Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Wockhardt Ltd Regulatory Filings 2021

Nov 1, 2021

59231_rns_2021-11-01_edcb7dac-d724-4f09-8a88-92dda9a58806.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

1[st] November, 2021

Ref. No.: WOCK/SEC/SE/2021-22/106

==> picture [167 x 46] intentionally omitted <==

BSE Limited Corporate Relations Department P J Towers Dalal Street Mumbai - 400 001

Scrip Code: 532300

National Stock Exchange of India Limited Exchange Plaza Bandra Kurla Complex Bandra (E) Mumbai - 400 051 NSE Symbol: WOCKPHARMA

Dear Sir/Madam,

Pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform the Exchanges that a meeting of the Board of Directors of the Company is scheduled to be held on 8[th] November, 2021, inter-alia , to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended 30[th] September, 2021.

In view of the above, the Trading window for dealing in the Shares of the Company, which was closed from 1[st] October, 2021, shall remain closed till 10[th] November, 2021. Accordingly, the Trading Window shall re-open with effect from 11[th] November, 2021.

Kindly take the above information on record.

Thanking you,

for Wockhardt Limited

==> picture [111 x 53] intentionally omitted <==

Debashis Dey Company Secretary

==> picture [106 x 46] intentionally omitted <==

==> picture [482 x 30] intentionally omitted <==